68 related articles for article (PubMed ID: 24629889)
1. [Effect of biliary obstruction on lipoprotein(a) concentration].
Calmarza P; Bajador E; Lapresta C; García Castañón S; de Castro I; Civeira F
Clin Investig Arterioscler; 2014; 26(5):218-23. PubMed ID: 24629889
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-X fifty years after its original discovery.
Fellin R; Manzato E
Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):4-8. PubMed ID: 30503707
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
5. Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype.
Cenarro A; Puzo J; Ferrando J; Mateo-Gallego R; Bea AM; Calmarza P; Jarauta E; Civeira F
Metabolism; 2014 Mar; 63(3):365-71. PubMed ID: 24333007
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
Ritland S
Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
[TBL] [Abstract][Full Text] [Related]
7. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma.
Motta M; Giugno I; Ruello P; Pistone G; Di Fazio I; Malaguarnera M
Minerva Med; 2001 Oct; 92(5):301-5. PubMed ID: 11675573
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
Muchacka-Bianga M; Deja G; Jarosz-Chobot P; Małecka-Tendera E; Kalina M; Grychtoł M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):25-30. PubMed ID: 16704858
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of lipoprotein-X (LP-X) in experimental bile duct obstruction.
Ritland S; Bergan A
Scand J Gastroenterol; 1975; 10(1):17-24. PubMed ID: 1124340
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein X (LP-X) in the differential diagnosis of cholestasis in children, with special reference to biliary atresia].
Duchnowska A; Wach K; Poradowska W
Probl Med Wieku Rozwoj; 1979; 8():84-91. PubMed ID: 263531
[TBL] [Abstract][Full Text] [Related]
13. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
Barra S; Cuomo V; Silvestri N; Materazzi C; Vitagliano G; Capozzi G; Caruso S; Gaeta G; Trevisan M
J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):482-6. PubMed ID: 21519277
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) concentrations in adult congenital heart disease patients.
Martínez-Quintana E; Rodríguez-González F
Congenit Heart Dis; 2014; 9(1):63-8. PubMed ID: 23701863
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups.
Konerman M; Kulkarni K; Toth PP; Jones SR
J Clin Lipidol; 2012; 6(4):368-73. PubMed ID: 22836074
[TBL] [Abstract][Full Text] [Related]
19. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
[TBL] [Abstract][Full Text] [Related]
20. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
